Cobimetinib and Irinotecan Liposome
| Autor: | J. Aubrey Waddell, Elizabeth B. Pickren, Dominic A. Solimando |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Pharmacology Cobimetinib medicine.medical_specialty Cancer chemotherapy business.industry Pharmacist Pharmacy 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine chemistry 030220 oncology & carcinogenesis Family medicine medicine Pharmacology (medical) Pharmacy practice business Irinotecan liposome |
| Zdroj: | Hospital Pharmacy. 51:208-211 |
| ISSN: | 1945-1253 0018-5787 |
| DOI: | 10.1310/hpj5103-208 |
| Popis: | *Dr. Pickren is a pharmacy practice resident (PGY 1) at Blount Memorial Hospital, Maryville, Tennessee. The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|